This inventor holds 3 USPTO granted patents. Top assignees: Teijin Limited, Other. Active years: 1978-1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hino, JP (1982)
- Tokyo, JP (1978 - 1992)
Company Filing History:
2 out of 1,605 
1 out of 834,513 Years Active: 1978-1992
Title: Shuzo Sawada: Innovator in Monoclonal Antibodies and IgM Derivatives
Introduction
Shuzo Sawada is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies and IgM derivatives. With a total of 3 patents, his work has implications for both diagnosis and therapy of infections.
Latest Patents
Among his latest patents, Sawada has developed the E87Ag antigens of Pseudomonas aeruginosa and monoclonal antibodies. This patent includes a P. aeruginosa E87Ag antigen comprising a polysaccharide fraction with a molecular weight of about 27,000, which is contained in the lipopolysaccharide of P. aeruginosa. Additionally, he has created an anti-P. aeruginosa human or mouse monoclonal antibody that recognizes the E87Ag antigen. Furthermore, he has developed a mouse-human or mouse-mouse hybridoma that produces this monoclonal antibody, which can be utilized for diagnosing and treating infections caused by P. aeruginosa. Another notable patent involves IgM derivatives and the process for their preparation. This patent focuses on introducing acyl groups to IgM derivatives to weaken their anticomplement activity by acylating the free amino groups present in IgM up to 1-90%.
Career Highlights
Throughout his career, Shuzo Sawada has worked with notable companies, including Teijin Limited. His innovative work has positioned him as a key figure in the biotechnology sector, contributing to advancements in medical diagnostics and therapeutics.
Collaborations
Sawada has collaborated with esteemed colleagues such as Yasuhiko Masuho and Gyozo Terui. These partnerships have further enhanced his research and development efforts in the field.
Conclusion
Shuzo Sawada's contributions to the field of biotechnology, particularly through his patents on monoclonal antibodies and IgM derivatives, highlight his role as an influential inventor. His work continues to impact the diagnosis and treatment of infections, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile